Medicine in Medical Technology

Montefiore Medical Center and Albert Einstein College of Medicine Herald New Agreement To Continue Forty-Plus Year Historic Relationship

New agreement outlines an increased level of commitment to clinical care, research and education NEW YORK, July 30 /PRNewswire-USNewswire/ -- Montefiore Medical Center and Albert Einstein College of Medicine of Yeshiva University today announced a new ten-year agreement to continue t...

Lilly Announces Positive Phase II Data on Investigational Medicine for Patients with Type 2 Diabetes

NEW ORLEANS, June 6 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) announced today new, positive Phase II study results of LY2189265, its investigational glucagon-like peptide 1 (GLP-1) analog administered subcutaneously once-weekly for the treatment of type 2 diabetes. These data ...

Study in the New England Journal of Medicine Shows Non-Surgical Treatment for Pre-Cancerous Condition of Esophagus is Effective and Reduces Risk for Cancer Development

Data show superiority of endoscopic ablation therapy using the HALO System for eradicating Barrett's esophagus in randomized, multicenter, sham controlled trial SUNNYVALE, Calif., May 27 /PRNewswire/ -- Results from a clinical study published today in the New England Journal of Medicine rev...

Landmark Study in The New England Journal of Medicine Shows HPV Testing Significantly Reduces Deaths from Cervical Cancer, Compared to other Methods Including Pap

QIAGEN donates one million tests to expand access to HPV screening in the world's poorest countries VENLO, Netherlands, April 1 /PRNewswire-FirstCall/ -- Results from an eight-year trial involving more than 130,000 women published today in The New England Journal of Medicine (NEJM) demonst...

Adlyfe Strikes Translational Medicine Partnership With Wyeth Pharmaceuticals for Alzheimer's Biomarker Assay

ROCKVILLE, Md., Feb. 25 /PRNewswire-USNewswire/ -- Adlyfe, a private company developing novel biomarkers and diagnostic tests for amyloid diseases, announced today that it has signed an agreement with Wyeth Pharmaceuticals, a division of Wyeth, to develop biomarker assays designed to measure level...

New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial

Data show comparable safety for complex patients treated with TAXUS(R) Express2(TM) Stents and bypass surgery NATICK, Mass., Feb. 18 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today welcomed the publication of results from its landmark SYNTAX(TM) trial in this week...

New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation

- Multaq(R) (dronedarone) significantly reduced the risk of cardiovascular hospitalization or death by 24 percent in patients with atrial fibrillation - PARIS, Feb. 11 /PRNewswire-FirstCall/ -- Sanofi-aventis (Paris Bourse: EURONEXT: SAN; and New York: NYSE: SNY ) announced today that the...

Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports

- Adding Zometa to post-surgery hormone therapy reduced risk of breast cancer return or death by 36% more than hormone therapy alone - First Phase III data to substantiate anticancer effect of Zometa - Zometa is the most widely prescribed drug for prevention of bone complications due to ...

ThermoGenesis Announces MXP Involvement in New Regenerative Medicine Initiatives

PROGRAMS INCLUDE BONE MARROW CLINICAL TRIAL IN ITALY RANCHO CORDOVA, Calif., Jan. 29 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL ), a leading supplier of innovative products and services that process and store adult stem cells, said today that its MarrowXpress(TM) (MXP(TM)) ...

Study of Cannabinoid Medicine for Pain Found Patients Got 'High,' but Effects Not Related to Pain Relief

HONOLULU, Jan. 28 /PRNewswire/ -- Researchers at Brigham and Women's Hospital found that patients taking cannabinoid medicines for pain may be getting "high," but these effects were unrelated to relief from their pain symptoms. Results of their study, one of the first to examine the addictive...

Advances in Science and Treatment of Pain Presented at 25th Annual American Academy of Pain Medicine Meeting January 28 - 31, 2009

Further Understanding of Pain as a Disease Leads to Innovation in Treatment GLENVIEW, Ill., Jan. 26 /PRNewswire/ -- The American Academy of Pain Medicine's (AAPM) 2009 Annual Meeting - its 25th Anniversary - will take place in Hawaii this week with over 200 scientific posters, presentations a...

Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients

WASHINGTON, Dec. 30 /PRNewswire-USNewswire/ -- The Coalition for 21st Century Medicine strongly opposes the citizen petition filed by Genentech, Inc. on December 5, 2008, seeking to restrict the ability of laboratories to offer diagnostic tests to physicians and patients. The request threatens in...

Two New Studies in the New England Journal of Medicine Show Malaria Vaccine Candidate Advancing in Africa

NEW ORLEANS, Dec. 8 /PRNewswire/ -- Results published online today in the New England Journal of Medicine revealed that the world's most clinically advanced malaria vaccine candidate provides both infants and young children with significant protection against malaria. Two separate phase II trials ...

GenVec Announces Multiple Presentations at the American Society of Tropical Medicine and Hygiene Meeting

Presentations Will Highlight Research Conducted in GenVec Malaria Vaccine Program GAITHERSBURG, Md., Dec. 5 /PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) announced today that the company will present on GenVec's malaria vaccine program at the American Societ...

New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients

- Patients in the VELCADE, melphalan and prednisone arm demonstrated a significant survival benefit as well as a 30 percent complete response - CAMBRIDGE, Mass., Aug. 27 /PRNewswire/ -- Millennium: The Takeda Oncology Company today announced the publication of results from the 682 patient, ...

The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer

- Nexavar is First Approved Systemic Therapy to Treat the Disease - WAYNE, N.J. and EMERYVILLE, Calif., July 23 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that The New England Journal of Medicine published results ...

CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Premier Registry Experienced Angina at One Year

-Study shows angina at one year associated with significantly higher incidence of depression- PALO ALTO, Calif., June 23 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX ) today announced that the Archives of Internal Medicine published results of a major...

European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals

Worldwide COGENT-1 Study of CGT-2168 Expands to Europe; Focus on Reducing Gastrointestinal Side Effects of Antiplatelet Therapy MENLO PARK, Calif., June 16 /PRNewswire/ -- Cogentus Pharmaceuticals, Inc. today announced that the first patient has been enrolled in Europe in the company's ...

The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxter's Cell-Based Pandemic, Avian Flu Vaccine

First scientific, peer-reviewed publication showing the candidate vaccine induced neutralizing antibodies against widely divergent H5N1 virus DEERFIELD, Ill., June 11 /PRNewswire-FirstCall/ -- Baxter International Inc. (NYSE: BAX ) announced publication in the June 12, 2008 issue of The New E...

CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCyte's Glycoprotein Products in Heart Attack Disease Model

BOTHELL, Wash., June 3 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (CellCyte) (OTC Bulletin Board: CCYG) has selected the Cardiovascular Phenotyping Core at Washington University School of Medicine in St. Louis to perform a study to further evaluate CellCyte's glycoprotein products...

New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study

Study Demonstrated Efficacy of RELISTOR for Use in Advanced-Illness Patients with Opioid-Induced Constipation COLLEGEVILLE, Pa. and TARRYTOWN, N.Y., May 28 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), and Progenics Pharmaceuticals, Inc. (N...

CellCyte Genetics Signs Collaborative Agreement With Northwestern University's Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCyte's CCG-TH30 Product Candidate

BOTHELL, Wash., May 28 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (CellCyte) (OTC Bulletin Board: CCYG) has entered into a collaborative research agreement with Northwestern University's Feinberg School of Medicine to perform an acute myocardial infarction (AMI) disease model stud...

Join NPR's David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer

GREENWICH, Conn., May 19 /PRNewswire/ -- Helix Health, the first U.S. stand-alone genomic medicine practice, is hosting a 90-minute webcast this Wednesday, May 21, 2008 from 1:00-2:30 PM EDT examining: How Genomic Medicine Is Changing the Management of Breast & Ovarian Cancer To register...

UltraShape(R) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Featured at American Society for Laser Medicine and Surgery Meeting

YOQNEAM, Israel and SAN RAMON, California, April 3 /PRNewswire/ -- Results of an independent multi-treatment clinical study of the UltraShape(R) Contour I, the first clinically proven non-invasive solution for fat reduction and body contouring using non-thermal selective focused ultrasound wil...

Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial

DENVER, March 3 /PRNewswire/ -- Pharmatech, Inc., a Research Management Organization (RMO), has contracted with Systems Medicine LLC (SML), a subsidiary of Seattle-based Cell Therapeutics, Inc. (CTI), to provide research and site management services for their phase II open-label clinical study...

QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Women's Health Issues

Project to Utilize World-Class Software & Database Developed in West Michigan to Help Advance Disease Diagnosis and Treatment Options VENLO, Netherlands and GRAND RAPIDS, Mich., Feb. 14 /PRNewswire/ -- The Center for Molecular Medicine (CMM) today announced the formation of a collaborativ...

Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168

MENLO PARK, Calif., Jan. 16 /PRNewswire/ -- Cogentus Pharmaceuticals, Inc. today announced that dosing has begun in a clinical study to confirm the full antiplatelet activity of its novel combination medicine CGT-2168. CGT-2168 is a once-daily capsule that combines clopidogrel (currently marke...

Hospital Launches Landmark Emergency Medicine Project

Innovative Concepts for ER One to be Studied for First Time in Patient Setting WASHINGTON, Jan. 10 /PRNewswire/ -- Washington Hospital Center took a major step forward today in the federally funded Project ER One initiative as it unveiled innovative technologies...

ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer

SAN MARINO, Calif., Dec. 18 /PRNewswire/ -- Epeius Biotechnologies Corporation announced today that the company has received a Certificate of Product Registration for Rexin-G(R) from the Philippine Bureau of Food and Drugs (BFAD), enabling the commercialization of its lead product as a safe an...

American Board of Internal Medicine President Named to Alzheimer's Study Group

PHILADELPHIA, Nov. 29 /PRNewswire-USNewswire/ -- Dr. Christine Cassel, expert and author on geriatrics and medical issues related to aging, has been named a member of the Alzheimer's Study Group (ASG), a new national task force co-chaired by former Speaker of the House Newt Gingrich and former...

Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day

Water bearers from Fort Point Channel to the Cyclorama mark 16th Annual 24-hour vigil BOSTON, Nov. 15 /PRNewswire-USNewswire/ -- Artist Michael Dowling is inviting thousands of youth to process with black and copper buckets filled with water from Fort Point Channel in South Boston into The B...

New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer

- First Study to Demonstrate Survival Benefit with ERBITUX in Patients with Colorectal Cancer Refractory to All Approved Chemotherapies - NEW YORK, Nov. 14 /PRNewswire-FirstCall/ -- ImClone Systems Incorporated (Nasdaq: IMCL ) and Bristol-Myers Squibb Company (NYSE: BMY ) announced today r...

The New England Journal of Medicine Publishes First Clinical Results for MedImmune's Chitinase-like Protein YKL-40 in Patients With Asthma

- Findings Suggest Protein May Play an Important Role in the Pathobiology of Severe Asthma, Identify Potential New Biomarker for Severity of Disease - GAITHERSBURG, Md., Nov. 14 /PRNewswire/ -- MedImmune, Inc. today announced the publication of the first clini...

American Legion Anticipates Institute of Medicine Report on Gulf War Veterans

WASHINGTON, Nov. 14 /PRNewswire-USNewswire/ -- The American Legion welcomes the findings of an Institute of Medicine (IOM) report on Deployment Related Stress scheduled to be released on Nov 14. "In view of the serious and widespread impact of stress on the health of military personnel who h...

University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites

PHILADELPHIA, Nov. 1 /PRNewswire/ -- A new study lead by James M. Metz, M.D., radiation oncologist at the University of Pennsylvania School of Medicine and presented by Charles Simone II, M.D., radiation oncologist at the National Cancer Institute concluded that when it comes to seeking inform...

Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers

CHICAGO, Oct. 16 /PRNewswire/ -- The Preimplantation Genetic Diagnosis International Society (PGDIS) is releasing a statement in response to a Practice Committee Opinion issued today by the American Society for Reproductive Medicine (ASRM). The rationale for determining chromosomal status in ...

U.S. Preventive Medicine Acquires Specialty Disease Management

DALLAS, Oct. 2 /PRNewswire/ -- U.S. Preventive Medicine(R) (http://www.USPreventiveMedicine.com ) a company organizing and commercializing the market for proactive preventive health services, announced today the acquisition of Specialty Disease Management Services, Inc., a national provider o...

Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless, States SafeMinds

"Study Findings and Limitations Require Further Investigations," Says Dissenting Panel Member ATLANTA, Sept. 26 /PRNewswire/ -- A Centers for Disease Control (CDC) study on the relationship between mercury (thimerosal) in vaccines and children's brain functioning draws ...

Personalized Medicine - The Genomic Revolution in Cardiac Care

WASHINGTON, Sept. 19 /PRNewswire-USNewswire/ --The Richard B. and Lynne V. Cheney Cardiovascular Institute and The Catherine Birch McCormick Genomics Center at The George Washington University host a cutting edge Symposium to examine the issues and implications around the growing forces of gen...

SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine

WASHINGTON, June 7 /PRNewswire/ -- BARI-2D is a useful and focused trial that builds on the body of scientific knowledge physicians use to provide the best possible care for diabetic patients with chronic stable angina and to evaluate their treatment options. The Society for Cardiovascular Angiog...